Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use

Clinical trial NCT01204866 · COMPLETED

Trial details

NCT number: NCT01204866
Sponsor: PharmAthene, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Reactions

Start date: 2010-07-01
Primary completion: 2010-08-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.